Initial reports were of infections confined to the central nervous system (CNS), predominantly in immunocompromised patients. More recently, disseminated infections have been described. The portal of entry is believed to be through the skin and airways. [4] [5] [6] [7] [8] We believe this is the first case of successfully treated disseminated acanthamoebiasis in a non-human-immunodeficiency-virus infected host who initially had skin lesions. We believe this is also the first reported case in which the organism was isolated from bronchoalveolar lavage.
The lesions were not tender, and there was no associated adenopathy. Typically, over the course of 72 to 96 hours, each of the subcutaneous nodules had the overlying erythema followed by the formation of a purpuric papule. The skin overlying the nodules did not spontaneously ulcerate.
Initial skin biopsy specimens were interpreted as suppurative granulomas possibly containing fungal elements, and the patient was started on amphotericin B and itraconazole. After many subsequent unsuccessful attempts to clarify the diagnosis on skin biopsy, a few samples revealed abscesses within the subcutaneous tissue. These abscesses contained abundant inflammatory cells, with a predominance of neutrophils and fibrinous debris. Numerous ovoid amoebic organisms were identified within the abscesses. The trophozoite forms were identified as Acanthamoeba. No organisms were identified on review of the previous biopsies.
Computed tomography and lumbar puncture showed no CNS involvement. Pentamidine, 5-fluorocytosine (5-FC), and topical chlorhexidine gluconate/ketoconazole cream were started. Amphotericin B was discontinued. The next week, the patient had new skin lesions, mostly over the head and neck, and then had respiratory failure, which required mechanical ventilation. A bronchoalveolar lavage revealed Acanthamoeba trophozoite forms. We added azithromycin to her regimen. In addition, the patient's azathioprine was discontinued, and the dose of tacrolimus was lowered to 1 mg/day, giving serum levels <5 ng/mL. She had gradual resolution of the skin lesions, and followup bronchoalveolar lavage 4 weeks later showed no presence of Acanthamoeba. Over the next 2 weeks, several medications for Acanthamoeba were discontinued because of side effects-azithromycin for development of torsades de pointes, 5-FC for nausea and vomiting, and pentamidine for pancreatitis. After a prolonged course, the patient improved and was extubated. During the latter part of her stay, the patient had abnormal liver function tests. Workup eventually led to a liver biopsy that showed the presence of Acanthamoeba. The patient was restarted on 5-FC and a lower dose of pentamidine with improvement in liver function tests.
Trichrome staining of the biopsy specimens revealed the organism to be Acanthamoeba castellani. Culture of skin specimens sent to the Centers for Disease Control (CDC) confirmed A castellani, susceptible to pentamidine and azithromycin. Serum samples sent to the CDC further confirmed infection with A castellani.
The patient was discharged after a 118-day hospitalization. She was discharged on clarithromycin and 5-FC. Twelve months after discharge, she remained well and without evidence of Acanthamoeba infection.
DISCUSSION
Acanthamoebae are well recognized as fatal opportunistic pathogens, especially in patients with the acquired immunodeficiency syndrome. [4] [5] [6] 9 Recently, cases after renal and bone marrow transplantation have been described, 3 ,10 and we believe that immunosuppressive drugs contribute to infection with the organism. Disseminated acanthamoebiasis is almost universally fatal, and the case reports of successfully treated Acanthamoeba infection were in patients with predominantly mucocutaneous findings. 4, 10 Early diagnosis of skin involvement is crucial because of the fatal nature of disseminated disease.
Cutaneous lesions are not pathognomonic and include papules, plaques, pustules, ulcers, eschars, nodules, and cellulitis. [3] [4] [5] [6] 10 Lesions of this kind can be seen in several types of disseminated infectious processes, and when routine cultures for bacteria, fungi, viruses, and mycobacteria are negative, Acanthamoeba should be considered.
In our case report, multiple biopsy specimens were necessary before the diagnosis was confirmed. Overlooking the amoebic organisms because of their resemblance to necrotic debris, histiocytes, and macrophages is possible if the pathologist is not alerted to the possibility of Acanthamoeba. In our case report, even retrospective review of the first biopsy specimens still did not reveal the organism, so multiple biopsy specimens may be necessary.
Wet preparations and cultures did not initially reveal any organisms, most likely because the fresh tissue was transported in plain saline. The organism was promptly identified when the transport medium was changed to Page's saline.
The time from the initial appearance of our patient's skin lesions to the diagnosis of Acanthamoeba was about 2 weeks. Whether earlier diagnosis and treatment could have prevented dissemination to the lungs and liver cannot be determined. It is likely that our patient had hematogenously disseminated disease at presentation. To ensure efficacy of therapy, Acanthamoeba should be sought in all tissues available. We believe this is the first report describing Acanthamoeba isolated from bronchoalveolar lavage.
Although there are no established therapies for disseminated Acanthamoeba infection, our patient's symptoms resolved clinically with itraconazole, pentamidine, 5-FC, and topical chlorhexidine gluconate/ketoconazole cream. Other authors have also treated Acanthamoeba successfully with this regimen. 4, 10 Further support for efficacy of this regimen includes the fact that she worsened clinically once the pentamidine and 5-FC were discontinued and improved clinically once these drugs were restarted. We favor this multidrug approach, if tolerated by the patient, because of the variable in vitro sensitivity of Acanthamoeba. 4, 6, 9 Lowering of the dose of the immunosuppressive drugs may have also played a significant role in our patient's recovery, and we believe this should be considered if anti-infective modalities alone are failing.
Typical skin lesion shows purpuric papule with peri-lesional hyperpigmentation on leg.
Although most reported cases of Acanthamoeba infection have been fatal, chemically immunosuppressed patients have been shown to survive if the organism was identified and therapy promptly initiated. Pentamidine, 5-FC, newer azole antifungals, and topical chlorhexidine gluconate/ketoconazole cream seem to be the most effective. Acanthamoebiasis in its many forms is now well described in the literature and should be in the differential diagnosis of any immunosuppressed patient with multiple skin nodules. A single biopsy that does not reveal Acanthamoeba when it is suspected should be repeated. Transport for culture and wet preparations should be in Page's saline.
